IP Library › Granted Patent US 11,712,413
Granted Patent B2
US 11,712,413 · App. 16/932,867 · Granted Aug 1, 2023

Halobacillus trueperi TCI66207 and bacterial lysate thereof and use of bactertal lysate

Inventors: Chu-Han Huang (Taipei, TW); Yung-Hsiang Lin (Taipei, TW)
Assignee: TCI CO., LTD.
A61K8/99A61Q19/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,712,413
App. No.
16/932,867
Granted
Aug 1, 2023
Kind
B2
Abstract

A Halobacillus trueperi TCI66207 strain, deposited in the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (Accession number DSM 33381). The H. trueperi TCI66207 strain has one or more of the following function: improving skin cell mitochondrion activity, promoting skin cell proliferation, maintaining skin corneum layer completeness, increasing expression of keratin (Keratin14) and/or hyaluronic acid synthase (HAS3) genes and promoting hyaluronic acid production.

Claims (6)

1. A composition comprising a bacterial lysate of Halobacillus trueperi TCI66207 strain, water, hydroxyacetophenone, hexalene glycol, 1,3-butanedione, xanthan gum and triethanolamine, wherein the H. trueperi TCI66207 strain is deposited in Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures under an accession number of DSM 33381.

2. The composition according to claim 1 , wherein the bacterial lysate improves skin cell mitochondrion activity.

3. The composition according to claim 1 , wherein the bacterial lysate promotes skin cell proliferation.

4. The composition according to claim 1 , wherein the bacterial lysate maintains the skin corneum layer structure and/or promotes hyaluronic acid production.

5. The composition according to claim 1 , wherein the bacterial lysate increases expression of Keratin14 and/or Hyaluronic acid synthase 3 genes.

6. The composition according to claim 1 , wherein the composition is a pharmaceutical composition or a cosmetic composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2020
From: HUANG, CHU-HAN; LIN, YUNG-HSIANG
To: TCI CO., LTD.
Reel/Frame 053247/0923 →
Continuity (2)
Provisional Application 62875997 · Jul 19, 2019
Related Publication 20210015736A1 · Jan 21, 2021
Cited By (1)
US 12,472,139